F0648-0027

F0648-0027 is a small molecule inhibitor of Signal Transducer and Activator of Transcription 3 (STAT3) dimerization. Identified through in silico screening of approximately 4.9 million compounds, it specifically blocks the protein-protein interactions required for STAT3 to form dimers and translocate to the nucleus. By inhibiting STAT3 activity, F0648-0027 suppresses the expression of downstream inflammatory mediators such as IL-6 and RANKL. In preclinical models of rheumatoid arthritis, specifically collagen-induced arthritis (CIA) in mice, the compound has demonstrated significant efficacy in reducing joint inflammation and destruction without apparent toxicity. It was developed by researchers at Keio University as a potential therapeutic candidate for autoimmune and inflammatory diseases.